News 2021-04-21
2021 Pharmaceutical Crystallization Summit
Breaking Drug Development Bottlenecks via Enabling Technologies
Physical & chemical properties of drug substance (DS) have major impacts on the formulation process & Drug Product (DP) properties or quality attributes. The final step in an API synthesis is usually crystallization or precipitation, serving as both purification and isolation. This international conference gathers industrial and academic subject matter experts to discuss their works related to DS crystallization and manufacturing opportunities (highlighted below)for new drug development programs.
(1) crystal structure prediction, (2) crystal shape prediction, (3) solubility assessment, (4) purification, and (5) analytical technologies
(1) co-processed API’s, (2) process intensification, (3) additive manufacturing, (4) adv. process control & automation, (5)modular systems
Please Click the image below to see more details.
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes

News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.